Shares of Arbutus Biopharma (ABUS) are up 10% in afternoon trading while those of Moderna (MRNA) are now down 3%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderna rises after Delaware court issues memo in patent fight with Arbutus
- Moderna’s CMV Vaccine Extension Study Reaches Completion, Setting the Stage for Next Growth Catalyst
- SPY ETF Daily Update, 2/2/2026
- SNDK, MU, CRM: January’s Best and Worst-Performing Stocks
- Moderna Stock Slips As Ambitious Cancer Trials Drag On